Teva UK Limited is recalling a
batch of methotrexate because
there have been a small number of
reports of damaged vials and there
are concerns, therefore, that there
is potential for a lack of sterility
assurance.
The Class 2 recall (within
48 hours) is being managed
in conjunciton with the UK’s
Medicines and Healthcare Products
Regulatory Agency (MHRA) and
relates to batch #12J30KC.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Dec 13
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.